Early Switch From Intravenous to Oral Antibiotics in Hospitalized Patients With Bacteremic Community-Acquired Streptococcus pneumoniae Pneumonia
Open Access
- 26 March 2001
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 161 (6), 848-850
- https://doi.org/10.1001/archinte.161.6.848
Abstract
THE AMERICAN Thoracic Society in 1993 suggested that, in hospitalized patients with community-acquired pneumonia (CAP), the initial intravenous therapy may be switched to oral therapy (switch therapy) once the patient shows evidence of early clinical improvement.1 Since then, several clinical trials have documented that performing switch therapy once the patient reaches clinical stability is associated with good clinical outcome, adequate patient satisfaction, and decreased length of hospital stay.2-6Keywords
This publication has 6 references indexed in Scilit:
- A Controlled Trial of a Critical Pathway for Treatment of Community-Acquired PneumoniaJAMA, 2000
- The utility of an in-hospital observation period after discontinuing intravenous antibioticsAmerican Journal Of Medicine, 1999
- Sequential Therapy With Cefuroxime Followed by Cefuroxime Axetil in Community-Acquired PneumoniaChest, 1997
- A Prediction Rule to Identify Low-Risk Patients with Community-Acquired PneumoniaNew England Journal of Medicine, 1997
- Evaluation of a pneumonia practice guideline in an interventional trial.American Journal of Respiratory and Critical Care Medicine, 1996
- Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysisJAMA, 1996